Pfizer (PFE) Sale and Maturity of Investments (2009 - 2026)
Pfizer's Sale and Maturity of Investments - Total was $2.53 billion in Q3 2026, down 18.3% from $3.1 billion a year earlier but up 19.2% from the prior quarter.
Powered by 
Analysis
Pfizer (PFE) Sale and Maturity of Investments (2009 - 2026) Analysis & Trends
On a trailing twelve-month basis, Pfizer's Sale and Maturity of Investments - Total was $20.94 billion through Sep 27, 2026, up 11.3% year-over-year; for FY2025, it was $25.37 billion, up 99.1% from FY2024.
- Sale and Maturity of Investments - Total shows a five-year compound annual growth rate of 16.5% (FY2020 to FY2025).
- In earlier years, Sale and Maturity of Investments - Total was $12.74 billion in FY2024 (-69.1%), $41.24 billion in FY2023 (-16.5%), $49.42 billion in FY2022 (+75.9%) and $28.1 billion in FY2021 (+137.9%).
- Quarterly Sale and Maturity of Investments - Total has moved between $297 million (Q2 2025) and $23.04 billion (Q4 2023) over five years.
- Compared with a year earlier, Sale and Maturity of Investments - Total was higher in three of the last six quarters, with growth averaging 106.1%.
- The best year-over-year quarter for Sale and Maturity of Investments - Total over five years was Q2 2026 (growth of 614.5%); the worst was Q4 2024 (a decline of 78.0%).
- Per Business Quant data, PFE's Sale and Maturity of Investments - Total in the three quarters before Q3 2026 was $2.12 billion (Q2 2026), $4.66 billion (Q1 2026) and $11.63 billion (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Investments Sold (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn | 308.00 Mn |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn | - |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn | 405.00 Mn |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - | 88.00 Mn |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn | - |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn | - |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn | 2.53 Bn |
| 10 | Vertex Pharmaceuticals | 138.73 Bn | 110.72 Bn | 2.91 Bn | 4.16 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 27, 2026 | 2.53 Bn |
| Jun 28, 2026 | 2.12 Bn |
| Mar 29, 2026 | 4.66 Bn |
| Dec 31, 2025 | 5.31 Bn |
| Sep 28, 2025 | 9.41 Bn |
| Jun 29, 2025 | 297.00 Mn |
| Mar 30, 2025 | 10.35 Bn |
| Dec 31, 2024 | 5.08 Bn |
| Sep 29, 2024 | 2.15 Bn |
| Dec 31, 2023 | 23.04 Bn |
| Oct 1, 2023 | 5.44 Bn |
| Jul 2, 2023 | 6.24 Bn |
| Apr 2, 2023 | 6.52 Bn |
| Dec 31, 2022 | 9.93 Bn |
| Oct 2, 2022 | 19.12 Bn |
| Jul 3, 2022 | 6.90 Bn |
| Apr 3, 2022 | 13.47 Bn |
| Dec 31, 2021 | 11.68 Bn |
| Oct 3, 2021 | 8.55 Bn |
| Jul 4, 2021 | 2.15 Bn |
API Access
Pfizer Sale and Maturity of Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=PFE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "sale-and-maturity-of-investments", "ticker": "PFE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=PFE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();